CN112206294A - Plaster for treating myopia and preparation method thereof - Google Patents

Plaster for treating myopia and preparation method thereof Download PDF

Info

Publication number
CN112206294A
CN112206294A CN202011421795.5A CN202011421795A CN112206294A CN 112206294 A CN112206294 A CN 112206294A CN 202011421795 A CN202011421795 A CN 202011421795A CN 112206294 A CN112206294 A CN 112206294A
Authority
CN
China
Prior art keywords
plaster
raw materials
fruit
medicine package
root
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011421795.5A
Other languages
Chinese (zh)
Inventor
郑钰辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wing Mu Tong Ltd
Original Assignee
Wing Mu Tong Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wing Mu Tong Ltd filed Critical Wing Mu Tong Ltd
Priority to CN202011421795.5A priority Critical patent/CN112206294A/en
Publication of CN112206294A publication Critical patent/CN112206294A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/638—Ligustrum, e.g. Chinese privet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/64—Orobanchaceae (Broom-rape family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9062—Alpinia, e.g. red ginger or galangal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a plaster for treating myopia and a preparation method thereof, belonging to the technical field of traditional Chinese medicines. The plaster for treating myopia comprises a first medicine bag, a second medicine bag and a third medicine bag, wherein the first medicine bag comprises the following raw materials: 8-12 g of feather cockscomb seed, 8-12 g of medlar, 3-6 g of astragalus root, 8-12 g of schisandra fruit, 12-18 g of cimicifuga foetida, 12-18 g of poria with hostwood, 12-18 g of sharpleaf galangal fruit, 18-22 g of cassia seed, 3-8 g of glossy privet fruit, 3-8 g of prepared rehmannia root, 1 momordica grosvenori, 6-11 g of fleece-flower root, 10-12 g of glossy ganoderma and 45-55 g of American ginseng. The invention can be used for treating myopia.

Description

Plaster for treating myopia and preparation method thereof
Technical Field
The invention relates to a plaster for treating myopia and a preparation method thereof, belonging to the technical field of traditional Chinese medicines.
Background
With the rapid development of electronic products, more and more electronic products can be contacted by primary and secondary school students, the using time is longer, the eye problems are more and more aged due to poor eye using habits and eye using environments, the eye problems become the problem which is not ignored in the growth process of teenagers, and the eye problems of the teenagers become the key point of the attention of parents, especially the myopia problem, which troubles many primary and secondary school students, and the existing myopia treatment methods are various, but have the problems of high cost, poor effect and the like.
Disclosure of Invention
The invention aims to provide a plaster for treating myopia and a preparation method thereof, and the plaster has the advantages of safe medication, low cost, good effect and convenient use.
The plaster for treating myopia comprises a first medicine bag, a second medicine bag and a third medicine bag, wherein the first medicine bag comprises the following raw materials: 8-12 g of feather cockscomb seed, 8-12 g of medlar, 3-6 g of astragalus root, 8-12 g of schisandra fruit, 12-18 g of cimicifuga foetida, 12-18 g of poria with hostwood, 12-18 g of sharpleaf galangal fruit, 18-22 g of cassia seed, 3-8 g of glossy privet fruit, 3-8 g of prepared rehmannia root, 1 momordica grosvenori, 6-11 g of fleece-flower root, 10-12 g of glossy ganoderma and 45-55 g of American ginseng.
Further, the second medicine package comprises the following raw materials: 45-55 g of mulberry fruit, 45-55 g of buddleja officinalis, 30-40 g of groundsel, 8-12 g of honey-fried licorice root and 3-8 g of saffron.
Further, the third medicine package comprises the following raw materials: 3-8 g of abalone shell, 3-8 g of pseudo-ginseng and 3-8 g of cistanche deserticola.
Further, the first medicine package comprises the following raw materials: 10 g of feather cockscomb seed, 10 g of medlar, 5 g of astragalus root, 10 g of Chinese magnoliavine fruit, 15 g of cimicifuga foetida, 15 g of poria with hostwood, 15 g of sharpleaf galangal fruit, 20 g of cassia seed, 5 g of glossy privet fruit, 5 g of prepared rehmannia root, 1 momordica grosvenori, 9 g of fleece-flower root, 11 g of lucid ganoderma and 50 g of American ginseng.
Further, the second medicine package comprises the following raw materials: 50 g of mulberry fruit, 50 g of pale butterflybush flower, 35 g of groundsel, 10 g of honey-fried licorice root and 5 g of saffron.
Further, the third medicine package comprises the following raw materials: abalone shell 5 g, notoginseng 5 g, broomrape 5 g.
The preparation method of the plaster for treating myopia comprises the following steps:
(1) crushing the raw materials in the first medicine package, adding 200-300 g of mineral water, and soaking for 20-40 minutes to obtain first material liquid;
(2) crushing the raw materials in the second medicine package, adding 200-300 g of mineral water, and soaking for 20-40 minutes to obtain second material liquid;
(3) decocting 200 g of honey for 8-12 minutes, adding the first material liquid, continuing to decoct for 45-60 minutes, adding the second material liquid, continuing to decoct into a paste, taking out the paste out of the pot;
(4) cooling the pasty medicine to 8-15 deg.C, smashing the third medicinal bag, adding into the pasty medicine, and stirring;
(5) and finally, 10 g of camphor and 10 g of borneol are added, and the plaster for treating myopia is obtained after molding.
The decoction time of the medicinal materials is determined according to the durability of each medicinal material.
The feather cockscomb seed has the effects of clearing liver-fire, improving eyesight and removing nebula. It is mainly used for treating liver heat with red eyes, nebula membrane generation, blurred vision, liver fire vertigo, etc. It is bitter and slightly cold in nature and flavor entering meridians, and enters liver meridian.
Saffron, recorded in pharmacopoeia as sweet and mild in nature and taste, has the main functions of nourishing blood, promoting blood circulation, enriching blood, promoting blood circulation and the like, and comprises the functions of promoting blood circulation to remove blood stasis, cooling blood and removing toxicity, relieving depression and soothing nerves, maintaining beauty and keeping young and the like. Meanwhile, during use, the health-care tea can regulate endocrine, particularly promote blood circulation in vivo, improve the oxygen supply capacity of blood, and has certain effects of improving the immunity and resistance of a human body, including improving the physique of the human body.
Ganoderma has sweet taste and warm nature, and can enter heart, spleen, kidney and lung meridians, and has effects of nourishing heart, tranquilizing mind, nourishing lung, invigorating qi, regulating qi-flowing, removing blood stasis, nourishing liver and invigorating spleen. It can be used for treating asthenia, listlessness, palpitation, insomnia, dizziness, cough, asthma, anorexia, and tachypnea.
With the progress of modern medical research, various pharmacological actions of ganoderma lucidum have been proved, which are specifically as follows:
1. the lucid ganoderma has the function of regulating immunity, can improve the activity and the number of immune cells in a human body, has the function of enhancing the immune function of an organism, particularly plays a certain role in liver injury and hepatitis virus replication inhibition, and has the functions of protecting the liver and detoxifying;
2. can be used for delaying aging. Researches show that polysaccharide components in the ganoderma lucidum can increase the activity of superoxide dismutase and help to remove in vivo oxidative free radicals, thereby achieving the effects of delaying senility and beautifying and protecting skin;
3. pharmacological research shows that the ganoderma lucidum has the function of dilating coronary artery, thereby being capable of helping to enhance coronary blood flow, improving blood circulation and playing a role in preventing cardiovascular and cerebrovascular diseases. It can also reduce cholesterol, lipoprotein and triglyceride in blood, and prevent atherosclerotic plaque formation;
4. has expectorant and antitussive effects, and can be used for extracting ganoderic acid from Ganoderma, relaxing airway smooth muscle, and eliminating phlegm and relieving cough in respiratory system;
5. the anti-tumor effect is to inhibit the angiogenesis of tumor and the growth of tumor cells, and is the anti-tumor effect of the ganoderma lucidum;
6. has effects of tranquilizing and allaying excitement, and has strong regulating effect on central system, so it has effects of tranquilizing and allaying excitement, and can be used for treating neurasthenia.
The combination of the feather cockscomb seed, the saffron and the ganoderma lucidum can achieve the effects of clearing liver and purging fire, improving eyesight and removing nebula, nourishing blood, promoting blood circulation, enriching blood and promoting blood circulation, and especially can promote blood circulation in vivo, improve the oxygen supply capacity of blood, and have certain effects of improving the immunity and resistance of human bodies, including improving the physique of the human bodies.
It can also introduce the properties and flavors of other herbs into the five zang-organs and six fu-organs to regulate the essence and qi of all zang-organs to reach the eyes, thereby improving vision.
Compared with the prior art, the invention has the beneficial effects that:
the invention uses common Chinese herbal medicines, and the three medicine bags are matched for use, so that the effects of nourishing blood, promoting blood circulation, enriching blood, promoting blood circulation and the like are achieved, the purposes of clearing liver and purging fire, improving eyesight and removing nebula are achieved, the invention is safe and reliable, green and pollution-free, and the effective rate can reach 98.5%.
Detailed Description
The present invention is further illustrated by the following specific examples.
Example 1
The plaster for treating myopia comprises a first medicine bag, a second medicine bag and a third medicine bag, wherein the first medicine bag comprises the following raw materials: 10 g of feather cockscomb seed, 10 g of medlar, 5 g of astragalus root, 10 g of Chinese magnoliavine fruit, 15 g of cimicifuga foetida, 15 g of poria with hostwood, 15 g of sharpleaf galangal fruit, 20 g of cassia seed, 5 g of glossy privet fruit, 5 g of prepared rehmannia root, 1 momordica grosvenori, 9 g of fleece-flower root, 11 g of lucid ganoderma and 50 g of American ginseng. The second medicine package comprises the following raw materials: 50 g of mulberry fruit, 50 g of pale butterflybush flower, 35 g of groundsel, 10 g of honey-fried licorice root and 5 g of saffron. The third medicine package comprises the following raw materials: abalone shell 5 g, notoginseng 5 g, broomrape 5 g.
The preparation method of the plaster for treating myopia comprises the following steps:
(1) crushing the raw materials in the first medicine bag, adding 250 g of mineral water, and soaking for 30 minutes to obtain a first feed liquid;
(2) crushing the raw materials in the second medicine bag, adding 250 g of mineral water, and soaking for 30 minutes to obtain a second feed liquid;
(3) decocting 200 g of honey for 10 minutes, adding the first material liquid, continuing to decoct for 50 minutes, adding the second material liquid, continuing to decoct into a paste, taking out the paste out of the pot;
(4) cooling the pasty medicine to 10 ℃, smashing the third medicine bag, adding the third medicine bag into the pasty medicine, and uniformly stirring;
(5) and finally, 10 g of camphor and 10 g of borneol are added, and the plaster for treating myopia is obtained after molding.
Example 2
The plaster for treating myopia comprises a first medicine bag, a second medicine bag and a third medicine bag, wherein the first medicine bag comprises the following raw materials: 8 g of feather cockscomb seed, 8 g of medlar, 3 g of astragalus root, 8 g of Chinese magnoliavine fruit, 12 g of cimicifuga foetida, 12 g of poria with hostwood, 12 g of sharpleaf galangal fruit, 18 g of cassia seed, 3 g of glossy privet fruit, 3 g of prepared rehmannia root, 1 momordica grosvenori, 6 g of fleece-flower root, 10 g of lucid ganoderma and 45 g of American ginseng. The second medicine package comprises the following raw materials: 45 g of mulberry fruit, 45 g of pale butterflybush flower, 30 g of groundsel, 8 g of honey-fried licorice root and 3 g of saffron. The third medicine package comprises the following raw materials: 3 g of abalone shell, 3 g of pseudo-ginseng and 3 g of desertliving cistanche.
The preparation method of the plaster for treating myopia comprises the following steps:
(1) crushing the raw materials in the first medicine bag, adding 200 g of mineral water, and soaking for 20 minutes to obtain a first feed liquid;
(2) crushing the raw materials in the second medicine bag, adding 200 g of mineral water, and soaking for 20 minutes to obtain a second feed liquid;
(3) decocting 200 g of honey for 8 minutes, adding the first material liquid, continuing to decoct for 45 minutes, adding the second material liquid, continuing to decoct into a paste, taking out the paste out of the pot;
(4) cooling the pasty medicine to 8 ℃, smashing the third medicine bag, adding the third medicine bag into the pasty medicine, and uniformly stirring;
(5) and finally, 10 g of camphor and 10 g of borneol are added, and the plaster for treating myopia is obtained after molding.
Example 3
The plaster for treating myopia comprises a first medicine bag, a second medicine bag and a third medicine bag, wherein the first medicine bag comprises the following raw materials: 12 g of feather cockscomb seed, 12 g of medlar, 6 g of astragalus root, 12 g of Chinese magnoliavine fruit, 18 g of cimicifuga foetida, 18 g of poria with hostwood, 18 g of sharpleaf galangal fruit, 22 g of cassia seed, 8 g of glossy privet fruit, 8 g of prepared rehmannia root, 1 momordica grosvenori, 11 g of fleece-flower root, 12 g of lucid ganoderma and 55 g of American ginseng. The second medicine package comprises the following raw materials: 55 g of mulberry fruit, 55 g of pale butterflybush flower, 40 g of groundsel, 12 g of honey-fried licorice root and 8 g of saffron. The third medicine package comprises the following raw materials: 8 g of abalone shell, 8 g of pseudo-ginseng and 8 g of desertliving cistanche.
The preparation method of the plaster for treating myopia comprises the following steps:
(1) crushing the raw materials in the first medicine bag, adding 300 g of mineral water, and soaking for 40 minutes to obtain a first feed liquid;
(2) crushing the raw materials in the second medicine bag, adding 300 g of mineral water, and soaking for 40 minutes to obtain a second feed liquid;
(3) decocting 200 g of honey for 12 minutes, adding the first material liquid, continuing to decoct for 60 minutes, adding the second material liquid, continuing to decoct into a paste, taking out the paste out of the pot;
(4) cooling the pasty medicine to 15 ℃, smashing the third medicine bag, adding the third medicine bag into the pasty medicine, and uniformly stirring;
(5) and finally, 10 g of camphor and 10 g of borneol are added, and the plaster for treating myopia is obtained after molding.
Example 4
The plaster for treating myopia comprises a first medicine bag, a second medicine bag and a third medicine bag, wherein the first medicine bag comprises the following raw materials: 8 g of feather cockscomb seed, 10 g of medlar, 6 g of astragalus root, 9 g of Chinese magnoliavine fruit, 16 g of cimicifuga foetida, 14 g of poria with hostwood, 13 g of sharpleaf galangal fruit, 21 g of cassia seed, 6 g of glossy privet fruit, 3 g of prepared rehmannia root, 1 momordica grosvenori, 7 g of fleece-flower root, 10 g of lucid ganoderma and 42 g of American ginseng. The second medicine package comprises the following raw materials: 52 g of mulberry fruit, 45 g of pale butterflybush flower, 33 g of groundsel, 11 g of honey-fried licorice root and 5 g of saffron. The third medicine package comprises the following raw materials: 6 g of abalone shell, 4 g of pseudo-ginseng and 7 g of desertliving cistanche.
The preparation method of the plaster for treating myopia comprises the following steps:
(1) crushing the raw materials in the first medicine bag, adding 250 g of mineral water, and soaking for 30 minutes to obtain a first feed liquid;
(2) crushing the raw materials in the second medicine bag, adding 250 g of mineral water, and soaking for 30 minutes to obtain a second feed liquid;
(3) decocting 200 g of honey for 10 minutes, adding the first material liquid, continuing to decoct for 50 minutes, adding the second material liquid, continuing to decoct into a paste, taking out the paste out of the pot;
(4) cooling the pasty medicine to 10 ℃, smashing the third medicine bag, adding the third medicine bag into the pasty medicine, and uniformly stirring;
(5) and finally, 10 g of camphor and 10 g of borneol are added, and the plaster for treating myopia is obtained after molding.
Test example:
200 myopia patients with vision of both eyes lower than 1.0 are randomly selected, the age is between 5 and 30 years old, conditioning is carried out for 15 to 30 days by using the product, the vision change condition is tested, the effect is shown when the vision is improved by more than 0.2, the effect is shown when the vision is improved by 0.1 to 0.2, and the effect is not changed when the vision is not improved.
The specific using method of the product of the invention is as follows: the product of the invention is applied to 15 acupuncture points of 1 Ingtang +2 Jingming +2 Yangbai +2 Tongziliao +2 forty-hundred +2 Yinaing +2 Waiguan +2 Fengguan +2 Taiyang acupuncture points of a human body by 15 times of each application of 0.1 g, and the application lasts for 10 to 12 hours each day.
And (3) testing results: wherein 187 patients have obvious effect, 10 patients have effect, 3 patients have no effect, and the total effective rate reaches 98.5%.
Typical cases are:
nie is that myopia is detected just after birth of a male and 10 years old, the vision of both eyes is about 0.5, and the vision of a child reaches 1.0 or more and reaches normal vision after conditioning for 20 days by wearing glasses from a small time.
Zhengding, female, 13 years old, myopia more than three years, left eye vision 0.3, right eye vision 0.5, trying a plurality of methods for correcting vision, not taking effect, using the product of the invention to recuperate for 24 days, the left eye vision reaches 1.0, the right eye reaches 1.1, reaching the normal vision range.
When a woman is 21 years old and is 11 years of myopia, the vision of the left eye and the right eye is 0.1, the eyesight of the user can be corrected by wearing the eye correction mask all the year round, the eyesight of the user can be corrected for 30 days by using the eye correction mask, the eyesight of the user can reach 1.0 in both eyes, and the normal vision range is reached.

Claims (7)

1. A plaster for treating myopia is characterized in that: comprises a first medicine package, a second medicine package and a third medicine package, wherein the first medicine package comprises the following raw materials: 8-12 g of feather cockscomb seed, 8-12 g of medlar, 3-6 g of astragalus root, 8-12 g of schisandra fruit, 12-18 g of cimicifuga foetida, 12-18 g of poria with hostwood, 12-18 g of sharpleaf galangal fruit, 18-22 g of cassia seed, 3-8 g of glossy privet fruit, 3-8 g of prepared rehmannia root, 1 momordica grosvenori, 6-11 g of fleece-flower root, 10-12 g of glossy ganoderma and 45-55 g of American ginseng.
2. A plaster for the treatment of myopia according to claim 1, wherein: the second medicine package comprises the following raw materials: 45-55 g of mulberry fruit, 45-55 g of buddleja officinalis, 30-40 g of groundsel, 8-12 g of honey-fried licorice root and 3-8 g of saffron.
3. A plaster for the treatment of myopia according to claim 1 or 2, wherein: the third medicine package comprises the following raw materials: 3-8 g of abalone shell, 3-8 g of pseudo-ginseng and 3-8 g of cistanche deserticola.
4. A plaster for the treatment of myopia according to claim 1, wherein: the first medicine package comprises the following raw materials: 10 g of feather cockscomb seed, 10 g of medlar, 5 g of astragalus root, 10 g of Chinese magnoliavine fruit, 15 g of cimicifuga foetida, 15 g of poria with hostwood, 15 g of sharpleaf galangal fruit, 20 g of cassia seed, 5 g of glossy privet fruit, 5 g of prepared rehmannia root, 1 momordica grosvenori, 9 g of fleece-flower root, 11 g of lucid ganoderma and 50 g of American ginseng.
5. A plaster for the treatment of myopia according to claim 2, wherein: the second medicine package comprises the following raw materials: 50 g of mulberry fruit, 50 g of pale butterflybush flower, 35 g of groundsel, 10 g of honey-fried licorice root and 5 g of saffron.
6. A plaster for the treatment of myopia according to claim 3, wherein: the third medicine package comprises the following raw materials: abalone shell 5 g, notoginseng 5 g, broomrape 5 g.
7. A preparation method of a plaster for treating myopia is characterized by comprising the following steps:
(1) crushing the raw materials in the first medicine package, adding 200-300 g of mineral water, and soaking for 20-40 minutes to obtain first material liquid;
(2) crushing the raw materials in the second medicine package, adding 200-300 g of mineral water, and soaking for 20-40 minutes to obtain second material liquid;
(3) decocting 200 g of honey for 8-12 minutes, adding the first material liquid, continuing to decoct for 45-60 minutes, adding the second material liquid, continuing to decoct into a paste, taking out the paste out of the pot;
(4) cooling the pasty medicine to 8-15 deg.C, smashing the third medicinal bag, adding into the pasty medicine, and stirring;
(5) and finally, 10 g of camphor and 10 g of borneol are added, and the plaster for treating myopia is obtained after molding.
CN202011421795.5A 2020-12-08 2020-12-08 Plaster for treating myopia and preparation method thereof Pending CN112206294A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011421795.5A CN112206294A (en) 2020-12-08 2020-12-08 Plaster for treating myopia and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011421795.5A CN112206294A (en) 2020-12-08 2020-12-08 Plaster for treating myopia and preparation method thereof

Publications (1)

Publication Number Publication Date
CN112206294A true CN112206294A (en) 2021-01-12

Family

ID=74068175

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011421795.5A Pending CN112206294A (en) 2020-12-08 2020-12-08 Plaster for treating myopia and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112206294A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102188604A (en) * 2010-03-09 2011-09-21 贺光民 Medicament for treating myopia and presbyopia
CN108186964A (en) * 2018-03-07 2018-06-22 郑钰辉 A kind of ointment and its preparation method for treating true myopia eye
CN110151866A (en) * 2019-06-21 2019-08-23 李美霖 A kind of nutritional supplement for improving eyesight and preparation method thereof and purposes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102188604A (en) * 2010-03-09 2011-09-21 贺光民 Medicament for treating myopia and presbyopia
CN108186964A (en) * 2018-03-07 2018-06-22 郑钰辉 A kind of ointment and its preparation method for treating true myopia eye
CN110151866A (en) * 2019-06-21 2019-08-23 李美霖 A kind of nutritional supplement for improving eyesight and preparation method thereof and purposes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
周爱娟: "中药内服联合针灸治疗青少年轻度近视", 《江西中医药》 *

Similar Documents

Publication Publication Date Title
CN103789177B (en) A kind of supplementing QI and nourishing YIN compound Taizi ginsen health promoting wine
CN111956753B (en) Medicinal and edible traditional Chinese medicine composition as well as preparation method and application thereof
CN102824472A (en) Medicinal liquor for females for invigorating Qi and nourishing blood
CN103859379A (en) Formula and preparation method of life cultivation and health preservation food helpful for improving memory
CN103859375A (en) Formula and preparation method of life cultivation and health preservation food helpful for enhancing immunity
CN103330021B (en) Health-preserving tea
CN109497227A (en) A kind of brown sugar Qi jujube Health care ginger tea
CN110664906B (en) Preparation method of health food with blood sugar reducing function
CN106490612A (en) A kind of women help cream and preparation method
CN106266239A (en) Improve compositions of memory and its preparation method and application
CN111358922A (en) Traditional Chinese medicine composition for warming and invigorating kidney yang and improving cold constitution and preparation method and application thereof
CN105861252A (en) Ganoderma lucidum health-care rice wine
CN104888158A (en) Folium apocyni veneti oral liquid for enhancing immunity and preparation method thereof
CN112206294A (en) Plaster for treating myopia and preparation method thereof
CN113974162A (en) Chinese pear syrup cubilose and preparation method thereof
CN112263654A (en) Plaster for treating amblyopia and preparation method thereof
CN106138974A (en) A kind of pharmaceutical composition improving Qi deficiency physique and a kind of medicine brick and preparation method thereof
CN104689107A (en) Traditional Chinese medicine for treating nearsightedness and preparation method thereof
CN115154548B (en) A Chinese medicinal oral liquid for enhancing immunity
CN104587076A (en) Traditional Chinese medicine lotion for treating conjunctivitis
CN113786470B (en) Traditional Chinese medicine composition for treating deficiency of both qi and blood, food containing traditional Chinese medicine composition and preparation method
CN108888720A (en) It is a kind of to improve the healthcare dietetic liquid slept and preparation method
CN107362239A (en) A kind of longan medicinal liquor
CN109106842B (en) A medicine for stopping smoking and its preparation method
CN107753589B (en) A Chinese medicinal composition for treating diabetes, and its preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210112